Key words: cyclophosphamide; hepatotoxicity; lupus of three intravenous methylprednisolone pulses, folnephritis; immunosuppressive therapy lowed by oral prednisone 0.5 mg/kg per day. A week later, while she was still nephrotic, it was decided to decrease prednisone to 0.3 mg/kg per day because of an elevated intraocular pressure, and oral cyclophos-
Introduction
phamide 100 mg per day (2 mg/kg per day) was introduced. At that time liver function tests were normal. Cyclophosphamide is an alkylating agent widely used A week later, white cell count was 4700/mm3 and in oncology, rheumatology, clinical immunology and cyclophosphamide was reduced to 75 mg per day. At nephrology. Cyclophosphamide may cause bone the end of the second week of treatment the patient marrow toxicity, bladder toxicity, gonadal toxicity, developed malaise, nausea, vomiting, pruritus, jaunand mutagenic effects [1 ] . At high doses the drug may dice, and dark urine. She was hospitalized again. also engender cardiac and lung toxicity [2 ] . In contrast On admission the main laboratory data were: plasma hepatoxicity is rare and usually mild. creatinine 0.8 mg/dl, total serum protein 4.9 g/dl, We report here the case of a patient with systemic serum albumin 2.6 g/dl, immunoglobulin ( Ig) G lupus erythematosus (SLE) who developed severe but 1177 mg/dl, IgA 262 mg/dl, IgM 71 mg/dl, white blood reversible jaundice 2 weeks after the beginning of cell count 2800/mm3 (with normal differential count), treatment with oral cyclophosphamide.
haematocrit 33%, haemoglobin 10.5 g/dl, platelet count 404 000/mm3. Serum C3 and C4 levels and anti-DNA antibodies had returned to normal values and anti-
Case report
smooth-muscle and antimitochondrial antibodies were negative. Urinalysis showed proteinuria 0.75 g/24 h. In A 27-year-old woman was referred to our Unit in the urinary sediment the isomorphic erythrocytes were October 1991 because of fever, malaise, arthralgias, too many to count and there were several bilirubin oedemas, and nephrotic syndrome. She showed elev-casts. High levels of serum bilirubin (8 mg/dl ), alkaline ated anti-DNA antibodies (542 UI/ml; normal value phosphatase (780 U/l ), and aspartate aminotransferbelow 100 UI/ml ), low serum C3 (17 mg/dl; normal ase (320 U/l ) were found ( Figure 1 ). Laboratory tests value 55-120 mg/dl ), low serum C4 (10 mg/dl; normal for viral hepatitis A, B, C, G were negative. Serological value 15-45 mg/dl ), normal plasma creatinine tests for cytomegalovirus, herpes virus, and toxoplasma ( 0.7 mg/dl ), and proteinuria of 4.5 g/24 h with dyswere also negative. Repeated ultrasonography of the morphic microhaematuria and cylindruria in the urine liver did not show either cholelithiasis or dilatation of sediment. A renal biopsy showed diffuse proliferative the hepatic ducts. The patient had never received blood lupus nephritis. After diagnosis, she was treated with products and was not taking any other drug likely to three intravenous methylprednisolone pulses of 1 g cause liver toxicity. Cyclophosphamide was stopped each every 24 h, followed by oral prednisone 0.5 mg/kg but jaundice continued to worsen ( Figure 1 ). per day for 1 month, which was then progressively During the third week of hospitalization the patient tapered to 10 mg per day. After 3 months of treatment, underwent liver biopsy, which revealed severe cholestproteinuria disappeared, urine sediment normalized asis, scanty inflammatory cell infiltration, and very few and she maintained in complete remission until March necrotic hepatocytes, confined to the areas of severe 1996 when fever, arthralgias, and nephrotic proteinuria cholestasis. Five weeks after cyclophosphamide was ( 5 g per day) with active urine sediment reappeared, stopped, liver enzymes and bilirubin began to improve associated with low C3 levels (23 mg/dl ) low C4 spontaneously, and completely normalized within 4 levels (12 mg/dl ), and raised anti-DNA antibodies ( 840 UI/ml ). She was treated again with a new course months from the onset of jaundice. ( Table 1 ). In the previously described cases liver toxicity became clinically evident after 2-40 This woman developed a severe and progressive jaunweeks of oral or intravenous cyclophosphamide dice a few days after starting cyclophosphamide, therapy. Two patients died of hepatic failure [5,10] whereas she had normal liver function before this while the other patients completely recovered after therapy. No evidence of infection due to viruses known cyclophosphamide was stopped. When performed, liver to cause hepatitis (A, B, C, G, CMV, EBV ) was found.
biopsy showed different histological pattern: (a) perivShe did not show any ultrasonographic evidence of enous hepatocyte necrosis [9], (b ) diffuse hepatocellucholelithiasis and/or biliary tract disease. The clinical lar destruction in conjunction with mild fatty and biochemical signs of SLE were improving when infiltration [8 ], (c) massive hepatic necrosis with only jaundice developed, so that a diagnosis of lupus hepatthe reticular framework and remaining sinusoids [5 ] itis was quite unlikely [3] , nor there were signs supand (d ) small hepatic vein damage and fibrosis [13 ] . porting a diagnosis of another autoimmune hepatitis Although the hepatotoxic mechanism of cyclophos-[4 ]. Instead there were other signs of cyclophosphamphamide is not completely clarified it has been hypoide toxicity such as leukopenia and severe monothesized that an abnormal hepatic conjugation of morphic haematuria, which might be attributed to acrolein (one of the cytotoxic metabolites of cyclobladder toxicity induced by cyclophosphamide. Liver phosphamide) was the main responsible for liver abnormalities resolved completely only some months dysfunction [14 ] . after cyclophosphamide withdrawn. We concluded In our patient liver biopsy showed severe cholestasis therefore that this patient suffered from a severe hepatic with minimal hepatocellular injury, a picture comtoxicity caused by cyclophosphamide.
pletely different from the patterns described in patients To the best of our knowledge only 12 cases [5-12 ] of severe hepatotoxicity caused by cyclophosphamide who developed hepatotoxicity caused by cyclophos- G 1980; rather recalls that reported in cases of cholestasis 69: 187-194 caused by other drugs such as oestradiol, chlorpromaz- 
